相关实验视频
Updated: Jul 30, 2026

04:23
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
[神经障碍儿科患者对便秘饮食治疗的反应]
Yasna Franulic1, Gerardo Weisstaub2, Salesa Barja3
1Departamento de Nutrición. Hospital Josefina Martínez.
Nutricion hospitalaria
|January 22, 2026
概括
在患有神经障碍的儿童中,便秘很常见. 饮食变化,包括增加液体和纤维,在大多数情况下有效地管理便秘,改善生活质量.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 神经学 神经学
- 临床营养学 临床营养学
背景情况:
- 便秘是神经障碍儿童中普遍存在的问题,但对饮食干预的证据有限.
- 了解影响便秘和治疗反应的因素对于这种脆弱人群至关重要.
研究的目的:
- 确定神经障碍儿童便秘的频率.
- 为了确定与便秘相关的因素.
- 评估饮食干预措施对这个群体便秘的有效性.
主要方法:
- 一项回顾性研究分析了146名患有神经障碍的儿童.
- 评估便秘的患病率,相关因素 (年龄,营养,运动功能,饮食,药物),以及对增加液体和纤维摄入量的反应.
- 使用统计分析 (STATA) 来确定显著的关联 (p < 0.05).
主要成果:
- 69%的患者经历了便秘,老年人和超重/肥胖儿童的风险更高.
- 饮食管理 (增加纤维和液体) 在58.4%的便秘儿童中带来了积极的反应.
- 博卢斯食是调节治疗反应的重要因素 (p = 0.03).
结论:
- 高便率需要在神经障碍儿童中采取有效的管理策略.
- 饮食调整提供了一种有利且潜在的成本效益较高的治疗方法.
- 优化饮食摄入量可以改善患者的结果和生活质量.
相关概念视频
Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...

